Dr. Beatrice Golomb, University of California San Diego, has been able to successfully publish a paper with four case reports of individuals suffering from Fluoroquinolone Toxicity.
Dr. Miriam J. de Jonge M.D., who herself was floxed has contacted me and asked me to post, what I feel, is a comprehensive and well documented “Dear Colleague” letter, informing other doctors of (FQ) toxicity. It can be used to foster patient/doctor discussions. It is available here to download.
Charles Bennett MD PhD Chair of the Center for Economic Excellence in Medication Safety and Efficacy, Bennett-flashUniversity of South Carolina will be speaking at the PharmedOut’s 5th Annual Conference on June 11-12, 2015 at Georgetown University about Fluoroquinolones..
Our FQ team will be working closely with Dr. Golomb as she takes research to the next level in the near future. Stay tuned here as I will be sure to inform the FQ community of any pertinent developments with her, along with developments with other researchers that we work with.
A simple three step action that logically links FQ’s to the ability to initiate delayed adverse “late effect” reactions. There are no grand leaps of faith or conjecture required to link the steps.
I would have to say that we are one of the most complex subset of patients that can be seen by a physician. More often than not, we often leave the average physician scratching his head as to how to diagnose or treat our condition. Keeping that context in mind, I have determined that I will never see another nurse practitioner again.
If the patient never connects the dots he/she may never uncover what the root cause of his/her mysterious illness is, or are given a default diagnosis that is a “catch all” for the medical community. Considering the day and age that we live in, it is one of the greatest medical travesties, that is of monumental proportions, that is continually being perpetrated on innocent individuals.